Agenus Appoints Dr. Jos Iglesias as Chief Medical Affairs Officer to Guide Global Medical Affairs and Early-Access Programs, Including Frances AAC
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the appointment of Jos Iglesias, M.D. as Chief Medical Affairs Officer, effective November 10, 2025. Dr. Iglesias...